The lowest percentage of TLS + cases was recorded for Luminal B-HER2 BC cases, and this together with a lack of TLS + HER2 subtype cases suggested a potential negative effect of HER2 overexpression on TLS development. This evidence concerns the gene ERBB2 and breast cancer.